Fundz
Real-time · AI · Cross-signal

Owlstone Medical just moved. Here's exactly what to do next.

Who to reach, what to say, and why now — on Owlstone Medical, plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your planRequest a demo
Watch the 2-minute tour · with sound

Owlstone Medical Enters into a Research Collaboration Agreement with the FDA

Sep 30, 2024over 1 year ago

Contract Type

agreement

CambridgeBiotechnologyHealth Care

Description

Owlstone Medical has entered into a five-year Research Collaboration Agreement with the FDA’s Center for Devices and Radiological Health (CDRH) - Office of Science and Engineering Laboratories (OSEL) to develop methods for the confident identification of individual chemicals in the complex mixture of breath. The goal of the collaboration is to develop Regulatory Science Tools (RSTs) for the identification of Volatile Organic Compounds (VOCs) in complex mixtures.

Company Information

Company

Owlstone Medical

Location

Cambridge, England, United Kingdom

About

Owlstone Medical is on a mission is to save 100,000 lives and $1.5bn in healthcare costs. We have developed the Breath Biopsy platform, using breath analysis for precision medicine and the early detection of disease. Our products and services are for research use only. Not for use in diagnostic procedures.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Owlstone Medical's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months